These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 8558205

  • 81. Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study.
    Chabot GG, Armand JP, Terret C, de Forni M, Abigerges D, Winograd B, Igwemezie L, Schacter L, Kaul S, Ropers J, Bonnay M.
    J Clin Oncol; 1996 Jul; 14(7):2020-30. PubMed ID: 8683232
    [Abstract] [Full Text] [Related]

  • 82. Circumvention of drug resistance in cisplatin-resistant sublines of the human squamous carcinoma cell line HLac 79 in vitro and in vivo.
    Bier H.
    Acta Otolaryngol; 1991 Jul; 111(4):797-806. PubMed ID: 1950544
    [Abstract] [Full Text] [Related]

  • 83. Inhibition of the protective effect of cyclophosphamide by pre-treatment with buthionine sulfoximine.
    Carmichael J, Friedman N, Tochner Z, Adams DJ, Wolf CR, Mitchell JB, Russo A.
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1191-3. PubMed ID: 3744939
    [Abstract] [Full Text] [Related]

  • 84. Depletion of tumour glutathione in vivo by buthionine sulphoximine: modulation by the rate of cellular proliferation and inhibition of cancer growth.
    Terradez P, Asensi M, Lasso de la Vega MC, Puertes IR, Viña J, Estrela JM.
    Biochem J; 1993 Jun 01; 292 ( Pt 2)(Pt 2):477-83. PubMed ID: 8503882
    [Abstract] [Full Text] [Related]

  • 85. Exogenous glutathione attenuates the antiproliferative effect of buthionine sulfoximine.
    Kang YJ.
    Toxicology; 1994 Mar 11; 88(1-3):177-89. PubMed ID: 8160199
    [Abstract] [Full Text] [Related]

  • 86. Differential sensitivities of murine melanocytes and melanoma cells to buthionine sulfoximine and anticancer drugs.
    Thrall BD, Raha GA, Springer DL, Meadows GG.
    Pigment Cell Res; 1991 Dec 11; 4(5-6):234-9. PubMed ID: 1823927
    [Abstract] [Full Text] [Related]

  • 87. Enhancement of EMT6/SF tumor cell killing by mitomycin C and cyclophosphamide following in vivo administration of buthionine sulfoximine.
    Ono K, Shrieve DC.
    Int J Radiat Oncol Biol Phys; 1986 Jul 11; 12(7):1175-8. PubMed ID: 3091546
    [Abstract] [Full Text] [Related]

  • 88. The effect of in utero administration of buthionine sulfoximine on rat development.
    Reyes E, Ott S, Robinson B, Contreras R.
    Pharmacol Biochem Behav; 1995 Apr 11; 50(4):491-7. PubMed ID: 7617692
    [Abstract] [Full Text] [Related]

  • 89.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 90. Relationship between melanogenesis, glutathione levels and melphalan toxicity in human melanoma cells.
    Benathan M, Alvero-Jackson H, Mooy AM, Scaletta C, Frenk E.
    Melanoma Res; 1992 Dec 11; 2(5-6):305-14. PubMed ID: 1337997
    [Abstract] [Full Text] [Related]

  • 91.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 92.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 93. The radiation dose-response relationship in a human glioma xenograft and an evaluation of the influence of glutathione depletion by buthionine sulfoximine.
    Halperin EC, Brizel DM, Honore G, Sontag MR, Griffith OW, Bigner DD, Friedman HS.
    Int J Radiat Oncol Biol Phys; 1992 Dec 11; 24(1):103-9. PubMed ID: 1512145
    [Abstract] [Full Text] [Related]

  • 94.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 95. Buthionine sulphoximine alone and in combination with melphalan (L-PAM) is highly cytotoxic for human neuroblastoma cell lines.
    Anderson CP, Tsai J, Chan W, Park CK, Tian L, Lui RM, Forman HJ, Reynolds CP.
    Eur J Cancer; 1997 Oct 11; 33(12):2016-9. PubMed ID: 9516845
    [Abstract] [Full Text] [Related]

  • 96. The effects of buthionine sulphoximine (BSO) on glutathione depletion and xenobiotic biotransformation.
    Drew R, Miners JO.
    Biochem Pharmacol; 1984 Oct 01; 33(19):2989-94. PubMed ID: 6148944
    [Abstract] [Full Text] [Related]

  • 97. Depletion of glutathione in vivo as a method of improving the therapeutic ratio of misonidazole and SR 2508.
    Yu NY, Brown JM.
    Int J Radiat Oncol Biol Phys; 1984 Aug 01; 10(8):1265-9. PubMed ID: 6236185
    [Abstract] [Full Text] [Related]

  • 98. Differential cytotoxicity of buthionine sulfoximine to "normal" and transformed human lung fibroblast cells.
    Wan XS, St Clair DK.
    Cancer Chemother Pharmacol; 1993 Aug 01; 33(3):210-4. PubMed ID: 8269602
    [Abstract] [Full Text] [Related]

  • 99. The effect of glutathione depletion by buthionine sulphoximine on 1-cyano-3,4-epithiobutane toxicity.
    VanSteenhouse JL, Fettman MJ, Gould DH.
    Food Chem Toxicol; 1991 Mar 01; 29(3):153-7. PubMed ID: 2032656
    [Abstract] [Full Text] [Related]

  • 100. Photodynamic therapy using Photofrin in combination with buthionine sulfoximine (BSO) to treat 9L gliosarcoma in rat brain.
    Jiang F, Lilge L, Belcuig M, Singh G, Grenier J, Li Y, Chopp M.
    Lasers Surg Med; 1998 Mar 01; 23(3):161-6. PubMed ID: 9779650
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.